SpeechPathology.com Phone: 800-242-5183


The Stepping Stones Group - We're Hiring - June 2026

What Should Clinicians Consider When Selecting a Comprehensive Test Battery to Assess Mild Cognitive Impairment?

Kim McCullough, PhD, CCC-SLP

July 1, 2026

Question

What should clinicians consider when selecting a comprehensive test battery to assess mild cognitive impairment?

 

Answer

The screening tools I have described help you determine what matters most and begin to understand the individual’s experience. But I want to be clear: these are not full standardized objective cognitive assessments. If you are looking to formally classify someone as having MCI, you need to use a comprehensive test battery. The literature offers some key recommendations to guide that choice (McCullough, Bayles, & Bouldin, 2019).

First, use an assessment with normative data. This is non-negotiable because normative data increases your ability to make valid judgments about whether a person’s performance is atypical for their age and education. Without normative comparison data, it is genuinely difficult to identify what is atypical. With MCI, the performance decrements are often subtle.

Second, use a comprehensive battery that assesses multiple cognitive domains. Because multi-domain impairment is associated with higher conversion risk, seeing patterns across multiple domains is clinically meaningful. When you see lower levels of performance across several measures and in more than one cognitive domain, you can feel more confident in an MCI diagnosis.

Third, use measures with a gradient of difficulty. This is what enables you to detect subtle impairments. If all items on a test are the same difficulty level, you will miss the nuanced performance differences that distinguish MCI from normal aging.

Fourth, assess episodic memory. Alzheimer’s disease is the most common cause of MCI and dementia, and its signature characteristic is episodic memory loss, specifically, rapid forgetting. Clinicians should therefore include an objective assessment of memory in both immediate and delayed recall conditions. Seeing how much a person retains after a delay is one of the most clinically informative data points you can have.

This Ask the Expert is an edited excerpt from the course, Mild Cognitive Impairment (MCI): Assessment and Treatment, presented by Kim McCullough, PhD, CCC-SLP.

Continued and its subsidiaries provide professional education authored by qualified Subject Matter Experts for continuing education purposes. These materials are intended for educational purposes and do not constitute medical advice or a substitute for individual clinical judgment. Continued is not a clinical healthcare provider; the licensed professional is solely responsible for ensuring that the application of any techniques or information presented is within their legal scope of practice and jurisdictional requirements.


kim mccullough

Kim McCullough, PhD, CCC-SLP

Kim McCullough, PhD, CCC-SLP, is a Professor and the Speech-Language Pathology Graduate Program Director at Appalachian State University. Kim is a certified speech-language pathologist with clinical expertise in providing services to individuals with neurogenic communication disorders. Kim’s clinical activities and research focus on aging, mild cognitive impairment, dementia, and interventions for sustaining brain function. Kim has worked with community partners for over two decades to provide multi-component cognitive wellness programs for older adults with concerns about changes in memory and thinking as well as with those who have a diagnosis of mild cognitive impairment or dementia. 

 


Related Courses

20Q: Mild Cognitive Impairment - The SLP’s Role in Service Delivery
Presented by Kim McCullough, PhD, CCC-SLP, Anne Hunter Cox
Text

Presenters

Kim McCullough, PhD, CCC-SLPAnne Hunter Cox
Course: #10527Level: Intermediate1 Hour
  'Clear presentation of information'   Read Reviews
Increasingly, SLPs are serving individuals with Mild Cognitive Impairment (MCI). MCI, cognitive reserve, and modifiable risk factors that can reduce the risk of dementia are defined and described in this course. An overview of cognitive/communicative deficits associated with MCI, as well as assessment and management considerations, is also provided.

Mild Cognitive Impairment (MCI): Assessment and Treatment
Presented by Kim McCullough, PhD, CCC-SLP
Video

Presenter

Kim McCullough, PhD, CCC-SLP
Course: #11362Level: Introductory1 Hour
  'I enjoyed the content and found it very interesting'   Read Reviews
With the growing prevalence of Mild Cognitive Impairment (MCI), speech-language pathologists play an important role in early identification and intervention. This course explores the characteristics of MCI and examines current best-practice guidelines for assessment and treatment.

Textbook: Cognitive Communication Disorders of MCI and Dementia - Definition, Assessment, and Clinical Management
Presented by Kim McCullough, PhD, CCC-SLP, Kathryn A. Bayles, PhD, ASHA Fellow, Cheryl Tomoeda, MS, CCC-SLP
Text

Presenters

Kim McCullough, PhD, CCC-SLPKathryn A. Bayles, PhD, ASHA FellowCheryl Tomoeda, MS, CCC-SLP
Course: #10911Level: Intermediate15.5 Hours
  'The text book was well written'   Read Reviews
Based on the textbook Cognitive Communication Disorders of MCI and Dementia: Definition, Assessment, and Clinical Management, this course provides the knowledge to diagnose and treat individuals with cognitive-communicative disorders associated with aging, mild cognitive impairment (MCI), and dementia-producing diseases, our fastest growing clinical population.

Treatment of Mild Cognitive Impairment
Presented by Kim McCullough, PhD, CCC-SLP
Video

Presenter

Kim McCullough, PhD, CCC-SLP
Course: #8633Level: Intermediate1 Hour
  'This course discussed the treatment of MCI'   Read Reviews
This course will focus on the treatment of MCI using current best practices. Intervention structure and content, as well as examples of strategies and activities for clinical implementation will be reviewed.

Dysphagia in Neurodegenerative Disease
Presented by Debra M. Suiter, PhD, CCC-SLP, BCS-S
Video

Presenter

Debra M. Suiter, PhD, CCC-SLP, BCS-S
Course: #9732Level: Intermediate1 Hour
  'Information was organized and presented nicely'   Read Reviews
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.